Anticoagulation of PE: which drugs, for how long?

G. Agnelli (Perugia, Italy)

Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management

Number: 10

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Agnelli (Perugia, Italy). Anticoagulation of PE: which drugs, for how long?. ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Pathophysiology Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management Year: 2017
Concomitant deep vein thrombosis: should we care? Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management Year: 2017
Diagnostic algorithm in suspected PE Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management Year: 2017
Comprehensive risk stratification in PE Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management Year: 2017
To thrombolyse or not to thrombolyse? Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management Year: 2017
Case presentation Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management Year: 2017
Case presentation Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management Year: 2017
Case presentation Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management Year: 2017
Case report Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management Year: 2017
Sleep and Breathing: an international conference in Prague, Czech Republic from March 31 to April 2, 2011 Source: Breathe 2011; 7: 217 Year: 2011
ERJ March Podcast: World TB Day 2017 Source: Eur Respir J , 49 (3) 17E4903; DOI: 10.1183/13993003.E4903-2017 Year: 2017
ERJ March Podcast: World TB Day Source: Eur Respir J, 51 (3) 18E5103; 10.1183/13993003.E5103-2018 Year: 2018
From acute PE to chronic thromboembolic pulmonary hypertension Source: ERS Online Course 2017 - Understanding pulmonary embolism: from pathophysiology to management Year: 2017
Welcome to the September 2018 issue of Breathe Source: Breathe, 14 (3) 174; 10.1183/20734735.025318 Year: 2018
Pulmonary function of the Zagreb general public – first world COPD day in Croatia (20^th November 2002) Source: Eur Respir J 2003; 22: Suppl. 45, 305s Year: 2003
ERJ January Podcast: The RESPIRE trials Source: Eur Respir J, 51 (1) 18E5101; 10.1183/13993003.E5101-2018 Year: 2018
ERJ February Podcast: Effectiveness versus efficacy Source: Eur Respir J, 51 (2) 18E5102; 10.1183/13993003.E5102-2018 Year: 2018
ERJ April Podcast: Observing dyspnoea in others Source: Eur Respir J, 51 (4) 18E5104; 10.1183/13993003.E5104-2018 Year: 2018
Emergency department visits and hospitalisations for asthma, COPD and respiratory tract infections: what is the role of respiratory viruses, and return to school in September, January and March? Source: ERJ Open Res, 6 (4) 00593-2020; 10.1183/23120541.00593-2020 Year: 2020
Occupational asthma in France: Trends over a 10 year observation period Source: Annual Congress 2010 - Occupational asthma: aetiology, persistence and quality of life Year: 2010